Baker McKenzie advised Abbott Laboratories on the deal. Abbott Laboratories executed the acquisition of Cardiovascular Systems, Inc. in an all-cash transaction valued at approximately $890 million. ...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here